John Hancock Income director buys 725 JHS shares
John Hancock Income Securities Trust director Kenneth J. Phelan reported buying common shares of beneficial interest in the fund.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
John Hancock Income Securities Trust director Kenneth J. Phelan reported buying common shares of beneficial interest in the fund. On January 27, 2026, he purchased 725 shares at an approximate price of $11.78 per share, bringing his directly held stake to 855 shares.
The filing notes the share price and corresponding share count are approximate because the fund’s net asset value is determined after the transaction, so the exact figures were not available at the time of this report.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Shares of Beneficial Interest | 725 | $11.78 | $9K |
Footnotes (1)
- F1. This figure is approximate. Due to the timing of the Fund's determination of its net asset value, the price per share, and the number of shares of the Fund that corresponds to, or held as a result of, the purchase cannot be determined at the time of this filing.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did JHS director Kenneth J. Phelan report?
What does the Form 4 footnote explain about the JHS transaction figures?
Is Kenneth J. Phelan a director or officer of John Hancock Income Securities Trust (JHS)?
Is the JHS stock owned by Kenneth J. Phelan held directly or indirectly?
AI-generated analysis. How Rhea-AI works. Not financial advice.